The DOI matches its Crossref record; 198 of the 201 references it cites were found in a registry or an index, and 1 are not checked yet.
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Open accessAbstract
Objective: This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology—Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence‐based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes from the prior guideline include consumer advocates added to the update group, evidence from 4 new clinical practice guidelines, 20 new systematic reviews, and 49 randomized control trials, enhanced emphasis on patient education and shared decision making, a new algorithm to clarify action statement relationships, and new and expanded recommendations for the diagnosis and management of OME. Purpose: The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants). Additional goals relate to OME surveillance, hearing and language evaluation, and management of OME detected by newborn screening. The target patient for the guideline is a child aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for all clinicians who are likely to diagnose and manage children with OME, and it applies to any setting in which OME would be identified, monitored, or managed. This guideline, however, does not apply to patients <2 months or >12 years old. Action Statements: The update group made strong recommendations that clinicians (1) should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing OME in a child; (2) should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both; (3) should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy; (4) should manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown); (5) should recommend against using intranasal or systemic steroids for treating OME; (6) should recommend against using systemic antibiotics for treating OME; and (7) should recommend against using antihistamines, decongestants, or both for treating OME. The update group made recommendations that clinicians (1) should document in the medical record counseling of parents of infants with OME who fail a newborn screening regarding the importance of follow‐up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss; (2) should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors; (3) should evaluate at‐risk children for OME at the time of diagnosis of an at‐risk condition and at 12 to 18 months of age (if diagnosed as being at risk prior to this time); (4) should not routinely screen children for OME who are not at risk and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort; (5) should educate children with OME and their families regarding the natural history of OME, need for follow‐up, and the possible sequelae; (6) should obtain an age‐appropriate hearing test if OME persists for 3 months or longer OR for OME of any duration in an at‐risk child; (7) should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development; (8) should reevaluate, at 3‐ to 6‐month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected; (9) should recommend tympanostomy tubes when surgery is performed for OME in a child <4 years old ; adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); (10) should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child ≥4 years old ; and (11) should document resolution of OME, improved hearing, or improved quality of life when managing a child with OME.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent otitis media CPGs recommend against the use of these agents.1974”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1974]
In the citing paper
“A key clinical feature of OME is hearing loss, due to decreased mobility of the tympanic membrane and consequent loss of sound conduction (Rosenfeld 2016).”
From Autoinflation for otitis media with effusion (OME) in children (2023) · cites this paper as Rosenfeld 2016
In the citing paper
“The National Institute for Health and Care Excellence (NICE) and the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) do not currently recommend the use of antibiotics, antihistamines, decongestants or corticosteroids for OME as there is insufficient evidence to suggest they are effective treatments (NICE 2008; Rosenfeld 2016).”
From Autoinflation for otitis media with effusion (OME) in children (2023) · cites this paper as Rosenfeld 2016
In the citing paper
“Other symptoms that may be attributable to OME include balance (vestibular) problems and ear discomfort (Rosenfeld 2016).”
From Autoinflation for otitis media with effusion (OME) in children (2023) · cites this paper as Rosenfeld 2016
In the citing paper
“Most episodes of OME in children resolve spontaneously within three months”
From Topical and oral steroids for otitis media with effusion (OME) in children (2023) · cites this paper as Rosenfeld 2016
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
American Speech‐Language‐Hearing Association
Weiner, F. F., & Ketzenberger, K. E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0119 · Cited by 2,557
Joint Committee on Infant Hearing (2007) · Pediatrics · doi:10.1542/peds.2007-2333 · Cited by 2,056
The Diagnosis and Management of Acute Otitis Media
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3488 · Cited by 1,442
Self-citationHealth Supervision for Children With Down Syndrome
Bull, M. J., & the Committee on Genetics (2011) · Pediatrics · doi:10.1542/peds.2011-1605 · Cited by 1,231
Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates
Monasta, L., Ronfani, L., Marchetti, F., Montico, M., Vecchi Brumatti, L., Bavcar, A., Grasso, D., Barbiero, C., & Tamburlini, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036226 · Cited by 1,101
Bess, F. H., Dodd-Murphy, J., & Parker, R. A. (1998) · Ear and Hearing · doi:10.1097/00003446-199810000-00001 · Cited by 847 · cited 1×
“Mild SNHL is associated with difficulties in speech, language, and academic performance in school, and persistent mild conductive hearing loss with OME may have a similar impact.(194,195) Moderate or greater hearing loss has been shown to affect speech, language, and school performance.”
BackgroundParadise, J. L., Rockette, H. E., Colborn, D. K., Bernard, B. S., Smith, C. G., Kurs-Lasky, M., & Janosky, J. E. (1997) · Pediatrics · doi:10.1542/peds.99.3.318 · Cited by 780
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Choudhry, N. K. (2002) · JAMA · doi:10.1001/jama.287.5.612 · Cited by 646
The Relationship Between Speech-Language Impairments and Reading Disabilities
Catts, H. W. (1993) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3605.948 · Cited by 617
Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review.
Vanderas, A. P. (1987) · PubMed · Cited by 554
Research works printed but not linked: 18
- Stool SE, 1994, Otitis Media with Effusion in Young Children: Clinical Practice Guideline No. 12
- Berkman ND, 2013, Otitis Media with Effusion: Comparative Effectiveness of Treatments. Comparative Effectiveness Review No. 101
- Rosenfeld RM, 2005, A Parent’s Guide to Ear Tubes
- Shekelle P, 2003, Diagnosis, Natural History and Late Effects of Otitis Media with Effusion: Evidence Report/Technology Assessment No. 55
- Casselbrant ML, Evidence‐Based Otitis Media, 147
- Qureishi A, 2014, Update on otitis media: prevention and treatment, Infect Drug Resist, 7, 15
- 10.1177/0194599812468849 · DOI · Paper page
- Onusko E, 2004, Tympanometry, Am Fam Physician, 70, 1713
- Ruben R, 2003, Evidence‐Based Otitis Media, 505
- Gravel JS, Evidence‐Based Otitis Media, 342
- Glade M, 1996, Diagnostic and Therapeutic Technology Assessment: Speech Therapy in Patients with a Prior History of Recurrent Acute or Chronic Otitis Media with Effusion
- 10.1097/00005537-200310000-00004 · DOI · Paper page
- 10.3109/00016488109133288 · DOI
- Maw AR, 1994, The long term outcome of secretory otitis media in children and the effects of surgical treatment: a ten year study, Acta Otorhinolaryngol Belg, 48, 317
- 10.1016/j.otohns.2004.02.002 · DOI · Paper page
- 10.1097/00003446-199810000-00001 · DOI · Paper page
- 10.1136/adc.2004.059444 · DOI
- 10.1001/jama.1990.03440150074029 · doi:10.1001/jama.1990.03440150074029 · Paper page
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759
A systematic review of interventions for children with cerebral palsy: state of the evidence
Novak, I., Mcintyre, S., Morgan, C., Campbell, L., Dark, L., Morton, N., Stumbles, E., Wilson, S., & Goldsmith, S. (2013) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12246 · Cited by 1,298
Estey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Metadata
- Authors
- Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., & Corrigan, M. D.
- Affiliations
- SUNY Downstate Health Sciences University (US)
- Harvard University (US)
- Virginia Mason Medical Center (US)
- Society for Middle Ear Disease Pittsburgh Pennsylvania USA
- Connecticut Pediatric Otolaryngology Madison Connecticut USA
- Pomona Pediatrics Pomona New York USA
- American Academy of Family Physicians (US)
- Cincinnati Children's Hospital Medical Center (US)
- University of Virginia Health System (US)
- Boston Children's Hospital (US)
- Children's Medical Center (US)
- Washington University in St. Louis (US)
- Consumers United for Evidence‐Based Healthcare Davis California USA
- American Academy of Otolaryngology — Head and Neck Surgery (US)
- Corresponding author
- Rosenfeld, Richard M.
- ORCID
- Venue
- Otolaryngology–Head and Neck Surgery
- Publisher
- Wiley
- Published
- 2016-02
- Volume
- 154
- Issue
- S1
- Pages
- S1-S41
- ISSN
- 0161-6439 (ISSN-L)
- 0194-5998
- 1097-6817
- OpenAlex
- W2218096687
- Cited by
- 2,006
- References
- 201
- Citations by year
- 2026: 32 · 2025: 54 · 2024: 95 · 2023: 78 · 2022: 86 · 2021: 103 · 2020: 85 · 2019: 72 · 2018: 70 · 2017: 62 · 2016: 36
- FWCI
- 77.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Otolaryngology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Keywords
- otitis media with effusion, middle ear effusion, pediatric patients, pneumatic otoscopy, tympanometry, expectant management, medical therapy, intranasal corticosteroids, antihistamines, decongestants, developmental disabilities, newborn screening, shared decision-making, patient education, quality improvement
- MeSH terms
- Child, Child, Preschool, Humans, Infant, Infant, Newborn, Otitis Media with Effusion, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Practice Guideline: Otitis Media with Effusion (Update). https://app.cochat.ai/papers/10.1177/0194599815623467
- The paper
- Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., Poe, D. S., Veling, M., Vila, P. M., Walsh, S. A., & Corrigan, M. D. (2016). Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology–Head and Neck Surgery. https://doi.org/10.1177/0194599815623467
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.